Evidence map›Paper›PMID 33524226›Full record

ArticlePediatric pulmonology2021

Pulmonary eosinophilic vasculitis with granulomas and benralizumab in children.

Daniel M Hinds, Jessica L Bloom, Jennifer C Cooper, Cullen M Dutmer, Csaba Galambos, Jason P Weinman, Michael E Wechsler, Deborah R Liptzin

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric pulmonology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel M HindsDepartment of Pediatrics, Section of Pediatric Pulmonology and Sleep Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0002-1291-741X
Jessica L BloomDepartment of Pediatrics, Section of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0002-7645-2084
Jennifer C CooperDepartment of Pediatrics, Section of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Cullen M DutmerDepartment of Pediatrics, Section of Allergy & Immunology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Csaba GalambosDepartment of Pathology and Laboratory Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Jason P WeinmanDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Michael E WechslerDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Deborah R LiptzinDepartment of Pediatrics, Section of Pediatric Pulmonology and Sleep Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0002-3667-1856

Funding

Research Training in Rheumatology INCLUDE Down Syndrome SupplementT32AR007534 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Kristine A. Kuhn · 1986 to 2026
$6.1M
NIAMS NIH HHS T32 AR007534
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Asthmatic AgentsAsthmaVasculitisAntibodies, Monoclonal, HumanizedChildEosinophilsGranulomaHumansAnti-Asthmatic AgentsAntibodies, Monoclonal, Humanizedbenralizumab

Identifiers

PMID33524226
PMCPMC8137646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.